Profund Advisors LLC Astrazeneca PLC Transaction History
Profund Advisors LLC
- $2.97 Billion
- Q3 2025
A detailed history of Profund Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Profund Advisors LLC holds 49,388 shares of AZN stock, worth $4.42 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
49,388
Previous 52,952
6.73%
Holding current value
$4.42 Million
Previous $3.7 Million
2.41%
% of portfolio
0.13%
Previous 0.14%
Shares
34 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...